Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
Intranasal immunization with recombinant Vaccinia virus encoding trimeric SARS-CoV-2 spike receptor-binding domain induces neutralizing antibody.
复制标题
DOI:
10.1016/j.vaccine.2022.08.054
复制
发表时间:
2022-09-22
期刊:
影响因子:
5.5
通讯作者:
Li, Yaoming
中科院分区:
文献类型:
--
作者:
Cao, Xiaoling;Zai, Junjie;Zhao, Qingzhen;Xie, Lilan;Li, Yaoming
Respiratory transmission of SARS-CoV-2 is considered to be the major dissemination route for COVID-19, therefore, mucosal immune responses have great importance in preventing SARS-CoV-2 from infection. In this study, we constructed a recombinant Vaccinia virus (VV) harboring trimeric receptor-binding domain (RBD) of SARS-CoV-2 spike protein (VV-tRBD), and evaluated the immune responses towards RBD following intranasal immunization against mice and rabbits. In BALB/c mice, intranasal immunization with VV-tRBD elicited robust humoral and cellular immune responses, with high-level of both neutralizing IgG and IgA in sera against SARS-CoV-2 psudoviruses, and a number of RBD-specific IFN-γ-secreting lymphocytes. Sera from immunized rabbits also exhibited neutralization effects. Notably, RBD-specific secretory IgA (sIgA) in both nasal washes and bronchoalveolar lavage fluids (BALs) were detectable and showed substantial neutralization activities. Collectively, a recombinant VV expressing trimeric RBD confers robust systemic immune response and mucosal neutralizing antibodies, thus warranting further exploration as a mucosal vaccine.
登录
查看更多内容
影响因子:
16.8
作者:
Huo, Jiangdong;Le Bas, Audrey;Naismith, James H.
通讯作者:
Naismith, James H.
影响因子:
2.2
作者:
Zhao, Wanbo;Wang, Xiaomei;Li, Yaoming
通讯作者:
Li, Yaoming
影响因子:
39.3
作者:
Liu Z;Xu W;Xia S;Gu C;Wang X;Wang Q;Zhou J;Wu Y;Cai X;Qu D;Ying T;Xie Y;Lu L;Yuan Z;Jiang S
通讯作者:
Jiang S
影响因子:
56.9
作者:
Yan, Renhong;Zhang, Yuanyuan;Zhou, Qiang
通讯作者:
Zhou, Qiang
影响因子:
16.6
作者:
Routhu NK;Cheedarla N;Bollimpelli VS;Gangadhara S;Edara VV;Lai L;Sahoo A;Shiferaw A;Styles TM;Floyd K;Fischinger S;Atyeo C;Shin SA;Gumber S;Kirejczyk S;Dinnon KH 3rd;Shi PY;Menachery VD;Tomai M;Fox CB;Alter G;Vanderford TH;Gralinski L;Suthar MS;Amara RR
通讯作者:
Amara RR